Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582927 | SCV000687855 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001307692 | SCV001497113 | uncertain significance | Ataxia-telangiectasia syndrome | 2022-04-17 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 2930 of the ATM protein (p.Cys2930Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of ataxia telangiectasia (Invitae). ClinVar contains an entry for this variant (Variation ID: 490747). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |